申请人:Astellas Pharma, Inc.
公开号:US08338429B2
公开(公告)日:2012-12-25
A 2-acylaminothiazole derivative or a pharmaceutically acceptable salt thereof having an excellent effect of proliferating human c-mpl-Ba/F3 cells and an activity of increasing platelets based on the effect of promoting the formation of megakaryocytic colonies. A compound or a pharmaceutically acceptable salt thereof useful in treating thrombocytopenia.
一种2-酰胺基噻唑衍生物或其药学上可接受的盐,具有促进人类c-mpl-Ba/F3细胞增殖和增加血小板的活性,基于促进巨核细胞集落形成的作用。一种化合物或其药学上可接受的盐,可用于治疗血小板减少症。